Number of Indian ANDA approvals by the U.S. FDA 2017-2019

Number of Indian ANDAs approved by the U.S. FDA from first half of 2017 to first half of 2019

Download
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Use Ask Statista Research Service

Release date

December 2018

Region

India, United States

Survey time period

H1 2017 to H1 2019

Supplementary notes

ANDA refers to Abbreviated New Drug Application (ANDA). An ANDA approval from U.S. Food and Drug Administration is required to market a generic drug in USA.
Note: The sample includes data of top five Indian pharma companies and the approvals exclude tentative approvals.
Data represents only the first half of the fiscal year for all three years. India's fiscal year starts in April and ends in March. For example, FY 2018 started in April 2017 and ended in March 2018.

Citation formats
Statista Accounts: Access All Statistics. Starting from $2,388 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$199 USD / Month *
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Other statistics that may interest you

Other statistics that may interest you Statistics on

About the industry

10

About the region

10

Selected statistics

9

Other regions

10

Related statistics

10

Further related statistics

10
Statista Accounts: Access All Statistics. Starting from $2,388 USD / Year
Learn more about how Statista can support your business.